Effectiveness of Repeat-dose CRD-4730 in Participants with CPVT
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-10-26
- Last Posted Date
- 2024-11-01
- Lead Sponsor
- Cardurion Pharmaceuticals, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT06658899
Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Preserved Ejection Fraction (Cycle-2-PEF)
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-01-22
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Cardurion Pharmaceuticals, Inc.
- Target Recruit Count
- 240
- Registration Number
- NCT06215586
- Locations
- π¬π§
Cardurion Investigative Site, London, United Kingdom
A Study to Assess Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Reduced Ejection Fraction (Cycle-1-REF)
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-01-22
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Cardurion Pharmaceuticals, Inc.
- Target Recruit Count
- 400
- Registration Number
- NCT06215911
- Locations
- π¬π§
Cardurion Investigative Site, London, United Kingdom
Effectiveness of CRD-4730 in Participants With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-08-22
- Last Posted Date
- 2024-10-26
- Lead Sponsor
- Cardurion Pharmaceuticals, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT06005428
- Locations
- πΊπΈ
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
πΊπΈCleveland Clinic Children's Hospital, Cleveland, Ohio, United States
πΊπΈBaylor College of Medicine, Houston, Texas, United States
Effect of Coadministration of Itraconazole on the Pharmacokinetics of CRD-740
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2022-06-29
- Last Posted Date
- 2023-02-06
- Lead Sponsor
- Cardurion Pharmaceuticals, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT05437094
- Locations
- πΊπΈ
Cardurion Investigative Site, Dallas, Texas, United States
Effectiveness of CRD-740 in Heart Failure
- First Posted Date
- 2022-06-08
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Cardurion Pharmaceuticals, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT05409183
- Locations
- π¬π§
Cardurion Investigative Site, Stockton-on-Tees, United Kingdom
Β© Copyright 2024. All Rights Reserved by MedPath